AR and breast carcinoma: By analyzing the correlation between AR status and pCR after neoadjuvant therapy in different subtypes of breast cancer, we found that only the TNBC pCR rate was correlated with AR expression status (P = 0.006), and AR-negative patients had a higher pCR rate.